Suresh Mahabhashyam
Chief Tech/Sci/R&D Officer bij CORVUS PHARMACEUTICALS, INC.
Profiel
Suresh Mahabhashyam is currently working as the Vice President-Clinical Development at Corvus Pharmaceuticals, Inc. He previously worked as the Senior Medical Director at Alexion Pharmaceuticals, Inc. from 2012 to 2015 and as the Vice President-Safety & Risk Management at Infinity Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Mahabhashyam holds a graduate degree from the University of North Texas Health Science Center and a doctorate degree from Bangalore Medical College & Research Institute.
Actieve functies van Suresh Mahabhashyam
Bedrijven | Functie | Begin |
---|---|---|
CORVUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2020 |
Eerdere bekende functies van Suresh Mahabhashyam
Bedrijven | Functie | Einde |
---|---|---|
INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2019 |
ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2015 |
Opleiding van Suresh Mahabhashyam
University of North Texas Health Science Center | Graduate Degree |
Bangalore Medical College & Research Institute | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CORVUS PHARMACEUTICALS, INC. | Health Technology |
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |